Company Profile
Updated: 11-NOV-09Amgen Inc.
Exporter
1 Amgen Center Dr., Thousand Oaks, CA 91320-1730, United States
(805)447-1000, (805)447-1010 fax, http://www.amgen.com
Primary SIC: Biological Products Except Diagnostic, Primary NAICS: Biological Product (except Diagnostic) Manufacturing
Description: Amgen Inc. was incorporated in 1980 and is a global biotechnology company that discovers, develops, manufactures and markets human therapeutics. Amgen markets human therapeutic products in the areas of supportive cancer care, nephrology, inflammation and oncology to healthcare providers including physicians, clinics, dialysis centers, hospitals and pharmacies. The company focuses research and development efforts on novel therapeutics for the treatment of grievous illness in the core areas of oncology, inflammation, bone and metabolic disorders. Amgen's manufacturing operations consist of bulk manufacturing, formulation, fill and finish activities for both commercial and clinical purposes. The company operates in one business segment - human therapeutics. Amgen maintains sales and marketing forces primarily in the United States, Europe and Canada. In the United States, the company sells primarily to wholesale distributors of pharmaceutical products. Outside the United States, Amgen sells principally to hospitals and wholesalers. The company has major research and development centers in several locations throughout the United States and in the United Kingdom, and has smaller centers in other countries throughout the world. Amgen operates commercial and clinical manufacturing facilities in several locations throughout the United States and in Puerto Rico. The company's principal products include Aranesp, EPOGEN, Neulasta, NEUPOGEN and Enbrel. More
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Primary Efficacy Endpoints.(Clinical report)
Heart Disease Weekly; 11/22/2009; 1091 words; ...president of Research and Development at Amgen. "As the first, large-scale placebo...reducing the need for transfusions." Amgen has shared this information with global...discussions are complete. Keywords: Amgen Inc., Anemia, Aranesp, Blood Transfusion...
Research reports from Amgen, Inc. provide new insights into proteomics.
Biotech Week; 11/18/2009; 870 words; ...wrote Z.Q. Zhang and colleagues, Amgen, Inc. The researchers concluded: "This...information, contact Z.Q. Zhang, Amgen Inc., Processing & Prod Development...United States, Thousand Oaks, Amgen Inc., Analytical Chemistry, Chromatography...
Prescribing Options for Treating Inflammation Positioned to Benefit from an Active Drug Pipeline.
Biotech Week; 11/18/2009; 928 words; ...TNF blocker, the pipeline includes two candidates from Amgen that take a new approach to inflammation by inhibiting...org Source: Greystone Associates Keywords: Aging, Amgen Inc., Biotechnology, Cimzia, Drug Development, Drugs...
Sucampo Pharmaceuticals Reports Financial Results for the Third Quarter of 2009.(Financial report)
Biotech Week; 11/18/2009; 1432 words; ...see also Sucampo Pharmaceuticals, Inc.). Net sales of Amitiza, as reported...October 2009, Sucampo Pharmaceuticals, Inc. announced that William L. Ashton...number of senior executive positions at Amgen Inc., including Business Unit Vice President...
Enterprise and Retail Speakers Showcasing Their Use of Video At Streaming Media West.
Defense & Aerospace Week; 11/18/2009; 974 words; ...Investments, Intuit, Safeway and Amgen will be speaking and presenting...Keywords: Information Today, Inc., Information Today, Inc., Entertainment, Technology...Entertainment, Information Today Inc., Internet, Lo, Lockheed Martin...
Manufacturing: Develops and manufactures human therapeutics based on advanced cellular and molecular biology.
Recent News Articles
- Researchers from Amgen, Inc. discuss findings in biotechnology business.
Biotech Week - October 07, 2009 - Reports summarize biotechnology business research from Amgen, Inc.
Biotech Week - September 30, 2009 - Researchers from Amgen, Inc. provide details of new studies and findings in the area of biotechnology business.
Biotech Week - September 30, 2009 - Pepperdine University and Biotech Supply Chain Team for Supply Chain Conference.(Alison Moore from Amgen Inc.)(Dave Malenfant from Alcon Laboratories Inc.)(Douglas B. Farry from McKenna, Long & Aldridge L.L.P.)(Conference notes)
Wireless News - September 23, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning